In vertebrates, the checkpoint-regulatory kinase Chk1 mediates cell-cycle arrest in response to a block in DNA replication or to DNA damaged by ultraviolet radiation. The activation of Chk1 depends on both Claspin and the upstream regulatory kinase ATR. Claspin is a large acidic protein that becomes phosphorylated and binds to Chk1 in the presence of checkpoint-inducing DNA templates in Xenopus egg extracts. Here we identify, by means of deletion analysis, a region of Claspin of 57 amino acids that is both necessary and sufficient for binding to Xenopus Chk1. This Chk1-binding domain contains two highly conserved repeats of approximately ten amino acids. A serine residue in each repeat (serine 864 and serine 895) undergoes phosphorylation during a checkpoint response. A mutant of Claspin containing non-phosphorylatable amino acids at positions 864 and 895 cannot bind to Chk1 and is unable to mediate its activation. Our results indicate that two phosphopeptide motifs in Claspin are essential for checkpoint signalling.
In vertebrates, the checkpoint-regulatory kinase Chk1 mediates cell-cycle arrest in response to a block in DNA replication or to DNA damaged by ultraviolet radiation. The activation of Chk1 depends on both Claspin and the upstream regulatory kinase ATR. Claspin is a large acidic protein that becomes phosphorylated and binds to Chk1 in the presence of checkpoint-inducing DNA templates in Xenopus egg extracts. Here we identify, by means of deletion analysis, a region of Claspin of 57 amino acids that is both necessary and sufficient for binding to Xenopus Chk1. This Chk1-binding domain contains two highly conserved repeats of approximately ten amino acids. A serine residue in each repeat (serine 864 and serine 895) undergoes phosphorylation during a checkpoint response. A mutant of Claspin containing non-phosphorylatable amino acids at positions 864 and 895 cannot bind to Chk1 and is unable to mediate its activation. Our results indicate that two phosphopeptide motifs in Claspin are essential for checkpoint signalling. E ukaryotic cells protect the integrity of their genomes by means of checkpoint mechanisms. For example, such regulatory mechanisms prevent entry into mitosis if there are stalled replication forks in the nucleus or if the genome has suffered DNA damage 1 . In vertebrates, ATR is responsible for the phosphorylation and activation of Chk1 in the presence of DNA replication blocks [2] [3] [4] [5] . In turn, Chk1 prevents mitotic entry by inhibiting Cdc25 and stimulating Wee1, both of which are crucial regulators of the Cdc2-cyclin B complex [6] [7] [8] [9] [10] . We have been using Xenopus egg extracts to study the regulation of Xenopus Chk1 (Xchk1). In this system, Xchk1 undergoes activation and mediates a cell-cycle delay in response to DNA replication inhibitors such as aphidicolin 2, 9, 11 . We have also identified some simple oligonucleotides that switch on the Xchk1-regulatory pathway. For example, a pre-annealed mixture consisting of poly(dA) 70 -poly(dT) 70 (hereafter referred to as pA-pT) induces the phosphorylation and activation of Xchk1 effectively 11 . The checkpoint-dependent activation of Xchk1 involves phosphorylation by the Xenopus homologue of ATR (Xatr) on four conserved SerGln/Thr-Gln (SQ/TQ) motifs. A mutant of Xchk1 that lacks these SQ/TQ motifs cannot serve as a substrate for Xatr and is unable to mediate a delay in the cell cycle 2 . We previously identified Claspin as a regulator of Chk1 in vertebrates 11 . In Xenopus egg extracts, Claspin associates with Xchk1 in the presence of checkpoint-inducing DNA templates. This binding requires the phosphorylation of Claspin in its carboxy-terminal region. In Claspin-depleted extracts, Xchk1 cannot undergo Xatr-mediated activation. Claspin shows some similarities with the budding and fission yeast Mrc1 proteins, which control the activation of Rad53 and Cds1, respectively 12, 13 . Likewise, Claspin shares functional characteristics with budding yeast Rad9 and fission yeast Crb2, which are required for the activation of Rad53 and Chk1 after DNA damage in their respective organisms [14] [15] [16] [17] [18] [19] . Thus, Claspin, Mrc1, Rad9 and Crb2 seem to comprise a class of protein that mediates the transmission of signals from the genome to checkpoint effector kinases.
Here we have examined the mechanism by which Claspin associates with Xchk1. Previously we showed that 35 S-labelled Claspin binds to Xchk1 in Xenopus egg extracts containing pA-pT and the phosphatase inhibitor tautomycin. There is negligible binding of Claspin to Xchk1 in the presence of a single-stranded oligonucleotide such as poly(dA) 70 (hereafter referred to as pA). We used this binding assay to determine the region of Claspin that is required for interaction with Xchk1. First, we produced truncations of the C-terminal end of Claspin (amino acids 776-1285), which binds well to Xchk1 (ref. 11). We found that all polypeptides containing amino acids 847-903 of Claspin could bind to Xchk1 ( Fig.  1a; representative binding assays are shown in Supplementary  Information Fig. S1 ). We decided to refer to the 847-903 fragment of Claspin as the Chk1-binding domain (CKBD).
The region corresponding to the CKBD of Claspin is well conserved in humans and Drosophila (Fig. 1b) . There are two short conserved repeats of ten amino acids in the Xenopus CKBD (residues 858-867 and 889-898; Fig. 1c ). The consensus for each repeated Chk1-binding (CKB) motif is ExxxLC(S/T)GxF. The Drosophila CG1326 gene product, a putative Claspin homologue, contains two similar repeats, whereas human Claspin has three such repeats (residues 910-919, 939-948 and 976-985). We could not discern a CKBD in the yeast Mrc1 proteins, which bind to Cds1/Rad53. Notably, there are many conserved serine residues in the Xenopus CKBD. Ser 864 and Ser 895 are located in the centre of each repeated CKB motif. In addition, there are two SQ motifs (Ser 875 and Ser 900) that are potential phosphorylation sites for the kinases ATR and ATM.
To examine whether the CKBD must be phosphorylated to associate with Xchk1, we first produced a glutathione S-transferase (GST)-tagged version of this domain (GST-CKBD). GST-CKBD was radiolabelled with 35 S in bacteria, incubated in egg extracts containing either pA or pA-pT plus tautomycin, and re-isolated with glutathione beads. We found that GST-CKBD is modified in the presence of pA-pT plus tautomycin but not in the presence of pA (Fig. 2a) . We treated the modified form of the CKBD with λ-phosphatase in the absence or presence of sodium vanadate, an inhibitor of this phosphatase. The modification of the CKBD was abolished by treatment with λ-phosphatase, indicating that it is due to phosphorylation (Fig. 2a) .
We incubated the various forms of the GST-CKBD in vitro with nickel agarose beads containing the Xchk1-GST-His 6 protein. We then re-isolated the beads and examined binding of the 35 S-labelled GST-CKBD. We observed that only the fully shifted, phosphorylated form of the GST-CKBD could bind to Xchk1. In addition, treatment with λ-phosphatase eliminated binding to Xchk1 (Fig. 2a) . We also found that it is essential to do the in vitro binding assays in the presence of a reducing agent such as 10 mM dithiothreitol. This requirement may reflect the fact that each of the two repeated motifs in the CKBD contains a conserved cysteine residue.
To identify the phosphorylatable residues that are important for binding of the CKBD to Xchk1, we prepared various mutant forms of this domain. First, we mutated two serines (Ser 864 and Ser 895) in the conserved sequence repeats (ExxxLCSGxF) to alanine to create the CKBD 2AG mutant. Second, we mutated both serines in the SQ motifs (Ser 875 and Ser 900) to alanine to produce the CKBD 2AQ mutant. Last, we replaced all of the serines and threonines in the CKBD with alanine except Ser 864 and Ser 895 to produce the CKDB 6A mutant. Wild-type CKBD and the three mutants were produced in reticulocyte lysates as 35 S-labelled polypeptides and assayed for binding to recombinant Xchk1 in egg extracts. We found that the CKBD 2AG mutant could not associate with Xchk1 (Fig. 2b) . By contrast, both CKBD 2AQ and CKBD 6A bound efficiently to Xchk1 (Fig. 2b) . We verified by 32 P labelling that Ser 864 and Ser 895 in the CKBD undergo phosphorylation in egg extracts ( Supplementary Information Fig. S2 ).
We also tested whether full-length variants of Claspin lacking either Ser 864 or Ser 895, or both, could interact with Xchk1. We used reticulocyte lysates to produce 35 S-labelled versions of fulllength Claspin, Claspin S864A , Claspin S895A and Claspin
S864AS895A
(Claspin 2AG ). We then incubated these labelled Claspin proteins and Xchk1-GST-His 6 in egg extracts containing either pA or pA-pT plus tautomycin. Wild-type 35 S-labelled Claspin bound well to Xchk1-GST-His 6 , but not to a control His 6 -GST protein, in the presence of pA-pT plus tautomycin (Fig. 3a) . By contrast, 35 S-labelled Claspin 2AG did not bind detectably to Xchk1 (Fig. 3a) . Although we did observe interaction of Xchk1 with the Claspin S864A and Claspin S895A single mutants, the binding was less than 5% of that observed for wild-type Claspin (Fig. 3a) .
In parallel with these studies, we also characterized the binding of Xchk1 and Claspin in extracts in which the DNA replication checkpoint was induced by treatment with aphidicolin (Fig. 3b) to egg extracts containing no sperm nuclei, sperm nuclei or sperm nuclei and aphidicolin. After a 100-min incubation, we immunoprecipitated Xchk1 from the extracts with antibodies against Xchk1 and examined the binding of radiolabelled Claspin by autoradiography. Wild-type 35 S-labelled Claspin was co-immunoprecipitated with Xchk1 from aphidicolin-treated egg extracts (Fig. 3b ). By contrast, there was no binding of 35 S-labelled Claspin 2AG to Xchk1 in the presence of aphidicolin (Fig. 3b) . Taken together, these findings indicate that phosphorylation on both Ser 864 and Ser 895 is required for efficient binding of Claspin to Xchk1 in egg extracts containing different checkpoint-inducing DNA templates.
To evaluate the role of Ser 864 and Ser 895 in the activation of Xchk1, we replaced endogenous Claspin in egg extracts with Claspin 2AG . First, we immunodepleted Claspin with affinity-purified antibodies and then we added back either recombinant wild-type His 6 -Claspin or the His 6 -Claspin 2AG mutant to the depleted extracts (Fig. 4a) . We then examined activation of Xchk1 in the various extracts (Fig. 4b, c) . We incubated Xchk1-GST-His 6 in the extracts in the presence of either pA or pA-pT plus tautomycin. As expected from previous results, Xchk1 underwent phosphorylation and a 3.5-fold increase in kinase activity in extracts containing pA-pT plus tautomycin (Fig. 4b, c) . By contrast, the phosphorylation-dependent activation of Xchk1 was strongly compromised in Claspindepleted extracts (Fig. 4b, c) .
The phosphorylation and activation of Xchk1 could be restored 1, 3, 5, 7, 9, 11, 13, 15 ) or pA-pT plus tautomycin (lanes 2, 4, 6, 8, 10, 12, 14, 16 ). The extracts also contained Xchk1-GST-His 6 bound to nickel agarose beads. Aliquots of the extracts (lanes 1, 2, 5, 6, 9, 10, 13, 14) and the re-isolated bead fractions (lanes 3, 4, 7, 8, 11, 12, 15, 16) were subjected to SDS-PAGE and autoradiography. 14) and Claspin S895A (lanes 15-18) were incubated in egg extracts containing pA (lanes 1, 3, 5, 7, 9, 11, 13, 15, 17) or pA-pT plus tautomycin (lanes 2, 4, 6, 8, 10, 12, 14, 16, 18). The extracts also contained Xchk1-GST-His 6 (lanes 5, 6, 9, 10, 13, 14, 17, 18) or His 6 -GST (lanes 1, 2) bound to nickel agarose beads. Aliquots of extracts were subjected to SDS-PAGE and autoradiography (lanes 3, 4, 7, 8, 11, 12, 15, 16) . The nickel beads were isolated, washed and subjected to SDS-PAGE and autoradiography (lanes 1, 2, 5, 6, 9, 10, 13, 14, 17, 18). The input lanes show 1% of the total added protein for the binding assays. b, 35 S-labelled Claspin (lanes 1-3, 7-9) and Claspin 2AG (lanes 4-6, 10-12) were incubated for 100 min in egg extracts containing no nuclei (lanes 1, 4, 7, 10), 3,000 sperm nuclei per µl (lanes 2, 5, 8 and 11), or both 3,000 sperm nuclei per µl and 100 µg ml 6, 9, 12) . Aliquots of the extracts were subjected to SDS-PAGE (lanes 1-6) . The extracts were immunoprecipitated with antibodies against Xchk1 (lanes 7-12) and subjected to SDS-PAGE and autoradiography.
by addition of wild-type His 6 -Claspin, but not by addition of His 6 -Claspin 2AG (Fig. 4b, c) . Consistent with the results described above, wild-type His 6 -Claspin, but not His 6 -Claspin 2AG , associated specifically with Xchk1-GST-His 6 in the presence of the checkpoint-inducing DNA template (Fig. 4b) . We also found that endogenous Xchk1 does not undergo checkpoint-dependent phosphorylation in egg extracts containing His 6 -Claspin 2AG (Fig. 4d) . Taken together, these results indicate that the binding of Claspin to Xchk1 is essential for Xchk1 activation, and that Ser 864 and Ser 895 are essential for this function of Claspin in egg extracts.
In principle, phosphorylation of Claspin on Ser 864 and Ser 895 might lead to conformational changes that expose a binding surface for Xchk1. Alternatively, these phosphorylated sites in Claspin might be located in phosphopeptide recognition sequences that dock with Xchk1. The CKBD is relatively small (57 amino acids) and shows limited sequence conservation outside the two short repeated sequences. Replacement of Ser 864 or Ser 895, or both, with glutamic acid abolishes binding to Xchk1 (data not shown), suggesting that Claspin requires two phosphate groups and not simply two negatively charged residues at these positions for this interaction. On the basis of these observations, it seems plausible that phosphorylation of Ser 864 and Ser 895 generates phosphopeptide motifs that are recognized by Xchk1.
There are numerous examples of protein-protein interactions that are mediated by phosphopeptide motifs in one of the binding partners 20, 21 . For example, the FHA domain is a phosphoaminoacid-specific binding module found in numerous proteins, including the checkpoint kinases Rad53, Cds1 and Chk2 (refs 14, 16, 22) . For budding yeast Rad53, the FHA domain mediates the binding of Rad53 to Rad9 after DNA damage. This process requires the Mec1-dependent phosphorylation of Rad9 (refs. 14, 23, 24) . It has been proposed that the docking of multiple Rad53 molecules onto a scaffold consisting of oligomerized Rad9 facilitates the intermolecular autophosphorylation and activation of Rad53 (ref. 16 ). There are many other examples in which kinases must form multimers before activation 20, 25, 26 . The two repeated phosphopeptide motifs in Claspin could facilitate the dimerization of Xchk1. Alternatively, Claspin may need to interact with multiple sites on one Xchk1 molecule to execute its function.
Because Xatr is an upstream regulator of Xchk1, it seems a logical candidate for the kinase that phosphorylates Ser 864 and Ser 895 in Claspin. Significantly, the sequence in which both Ser 864 . b, Recombinant Xchk1-GST-His 6 was added to mock-depleted extracts (lanes 1, 2) and Claspindepleted extracts (lanes 3-8) containing no recombinant Claspin (lanes 3, 4), His 6 -Claspin (lanes 5, 6) or His 6 -Claspin 2AG (lanes 7, 8) . The extracts were incubated for 100 min in the presence of tautomycin plus pA (lanes 1, 3, 5, 7) or pA-pT ( lanes  2, 4, 6, 8 ). Xchk1-GST-His 6 was re-isolated with glutathione beads. Half of each sample was subjected to immunoblotting with antibodies against GST to detect Xchk1 (middle) or antibodies against Claspin (top). The rest was assayed for kinase activity with a GST-Cdc25 peptide substrate (bottom). c, Quantification of kinase assays shown in b. Values are the means ± s.d. from two experiments. d, Phosphorylation of endogenous Xchk1 is abolished in egg extracts containing the Claspin 2AG mutant. The indicated extracts were incubated for 100 min with 3,000 sperm nuclei per µl and 100 µg ml −1 aphidicolin and subsequently immunoblotted with antibodies that detect phosphorylation of Ser 344 in Xchk1 (top) or the whole Xchk1 protein (bottom).
and Ser 895 are embedded (LCSG) does not resemble the consensus recognition sequence for ATR. Many studies have established that both ATR and ATM have a strong preference for SQ/TQ motifs 27, 28 . We have not been able to detect phosphorylation by Xatr of Ser 864 and Ser 895 in the CKBD (data not shown). In Xatrdepleted extracts, however, the phosphorylation-dependent mobility shift of Claspin is largely abolished and the binding of Claspin to Xchk1 is abrogated (Supplementary Information Fig. S3 ).
In addition, immunoblotting studies with antibodies that recognize phosphorylated Ser 864 of Claspin indicate that Ser 864 of Claspin is not phosphorylated in aphidicolin-containing extracts that lack Xatr (Supplementary Information Fig. S3 ). We suspect that Ser 895 is also not phosphorylated in these extracts, although we have not examined this issue directly. Further studies will be required for conclusive identification of the kinase that phosphorylates Ser 864 and Ser 895 in the CKBD. Notably, Claspin contains 12 SQ/TQ motifs, including 2 conserved ones in the CKBD itself. Although the SQ motifs in the isolated CKBD are not required for CKBD binding to Xchk1, it is possible that phosphorylation of SQ/TQ motifs in the full-length Claspin molecule might regulate accessibility of the CKBD or other functional properties of Claspin.
Methods

Production of 35 S-labelled proteins
Truncated fragments of Claspin were labelled with 35 S-methionine (Amersham-Pharmacia, Piscataway, NJ) by using template DNAs generated by polymerase chain reaction (PCR) with the TNT-T7 Quick for PCR DNA kit (Promega, Madison, WI). PCR-generated templates were synthesized using pBS-Claspin (ref. 11) or pGEX-CKBD (see below) and the appropriate oligonucleotide primers. The 5′ primers contained the T7 promoter sequence. We produced pBS-Claspin S864A , pBS-Claspin S895A and pBS-Claspin S864AS895A by using the QuikChange kit (Stratagene, La Jolla, CA). 35 S-labelled full-length Claspin protein and its point mutants were synthesized by the TNT-T7-coupled reticulocyte lysate system (Promega).
Assay for Claspin binding to Xchk1 in Xenopus extracts
We incubated Xchk1-GST-His 6 protein (5 µg) bound to nickel agarose beads (10 µl) and 35 S-labelled truncated Claspin proteins for 100 min in Xenopus interphase egg extracts (100 µl) containing 100 µg ml −1 cycloheximide and either 50 µg ml −1 pA or 50 µg ml −1 pA-pT plus 3 µM tautomycin. The beads were washed three times with buffer A (10 mM HEPES-KOH at pH 7.5, 150 mM NaCl, 0.1% CHAPS, 2.5 mM EGTA and 20 mM β-glycerolphosphate) and once with HEPES-buffered saline (HBS; 10 mM HEPES-KOH (pH 7.5) and 150 mM NaCl). Bound proteins were subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE) and detected by a phosphorimager. Small polypeptides were separated in Tricine-containing gels.
Production of GST-CKBD polypeptides
A DNA fragment encoding amino acids 847-903 of Claspin was amplified by PCR and cloned into pGEX-2T to create pGEX-CKBD. We produced pGEX-CKBD 2AG , pGEX-CKBD 2AQ and pGEX-CKBD 6A with the QuikChange kit. Recombinant proteins were produced in CodonPlus (RIL) E. coli cells (Stratagene). Various 35 S-labelled GST-CKBD polypeptides were produced in CodonPlus (RIL) cells grown in M9 media containing 35 S-Translabel (ICN, Costa Mesa, CA).
In vitro assay for GST-CKBD binding to Xchk1
35
S-labelled GST-CKBD polypeptides (2.5 µg) were incubated for 100 min in interphase extracts (100 µl) containing 100 µg ml −1 cycloheximide and either 50 µg ml −1 pA or 50 µg ml −1 pA-pT plus 3 µM tautomycin. The extracts were diluted with 200 µl buffer A and centrifuged through a Sephadex G-25 column that had been equilibrated with the same buffer to remove endogenous glutathione. We incubated the flow-through fraction with 20 µl of glutathione beads for 30 min. The beads were washed three times with buffer A and once with HBS. Bound proteins were eluted with 20 mM glutathione in 50 mM Tris-HCl (pH 8.0). We incubated the 35 S-labelled GST-CKBD polypeptides in the glutathione eluate fractions for 30 min at 4°C with Xchk1-GST-His 6 protein bound to nickel agarose beads in buffer A containing 0.1 mg ml −1 bovine serum albumin and 10 mM dithiothreitol. The beads were washed three times with buffer A, once with HBS and subjected to SDS-PAGE.
Production of antibodies to phosphorylated Ser 864
The peptide ELLDLCSGQFK (residues 858-868 of Claspin) was synthesized with a phosphate on Ser 864, conjugated with keyhole limpet hemocyanin and injected into rabbits. We purified the resultant antibodies by affinity chromatography.
1 Figure S1 Assay for identification of the CKBD. Representative 35 S-labeled fragments of Claspin (amino acids 776-1285, left; and amino acids 838-920, right) were incubated in Xenopus egg extracts containing pA (lanes 1, 4, 7, 9), pA-pT (lanes 2, 5), or both pA-pT and tautomycin (lanes 3, 6, 8, 10) in the presence of Xchk1-GST-His6 bound to nickel agarose beads. After 100 min, aliquots of the extracts were subjected to SDS-PAGE (lanes 1-3, 7, 8) . The beads were isolated, washed, and subjected to SDS-PAGE and autoradiography to assess the binding of truncated Claspin proteins to Xchk1 (lanes 4-6, 9, 10). Figure S2 Ser-864 and Ser-895 in the CKBD are phosphorylated in egg extracts. GST-CKBD-6A (a), GST-CKBD-6A-S864A (b), and GST-CKBD-6A-S895A (c) were incubated in egg extracts containing pA-pT, tautomycin, and 32 P orthophosphate. The various GST-CKBD polypeptides were isolated with glutathione beads and subjected to SDS-PAGE and autoradiography. The 32 P-labeled GST-CKBD polypeptides were digested with trypsin and endoproteinase Glu-C. The resulting peptides were separated by two-dimensional electrophoresis and chromatography. The dots in each left lower corner indicate the origins where peptides were loaded before separation. In the case of the S864A mutant, a spot was missing in the upper right hand corner of the phosphopeptide map. Similarly, for the S895A mutant, two closely spaced spots were absent from the lower right hand region of the map. The two spots are most probably due to incomplete digestion with endoproteinase Glu-C, rather than incomplete alkylation, since digestion with trypsin alone yielded only one 32 P-labeled spot corresponding to the Ser-895-containing peptide.
